Yangzhenhua 851

MENU

  • HOME

  • ABOUT US

    • Company Profile

    • Inventor

    • Origin of 851

    • Company News

    • Overseas Market

  • PRODUCTS

  • RESEARCH FRONT

  • CONTACT US

  • 中文版

Researchtheme on anti-aging and others

Efficacy and toxicity studies on unique branched chain fatty acids and their derivatives as potential anticancer agents

2021-02-24

READ MORE>>

Q-CAN® Plus Fermented Soy ("QC") vs Control FINAL Statistical Report Table of Contents

2021-02-24

READ MORE>>

Prostate-Specifc Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer

2021-02-24

Measurements At the baseline, at 6 months, and optionally at 12 months, blood samples were obtained for PSA measurement. A DRE was performed at baseline and all follow-up visits. TRUS or multipara-met

READ MORE>>

prolonged stabilization of amyotrophic lateral sclerosis (ALS) with a Specially Fermented Soy Produ.t (FSWW08): Case Repart and Discussion

2021-02-24

READ MORE>>

Japan NK Cell Study in English Results

2021-02-24

READ MORE>>

Autoimmune Diseases – New Therapy Approaches

2021-02-24

READ MORE>>

< 1...678...10 > proceed page

Categories

Submit
%{tishi_zhanwei}%

Categories

851 International Research

Newspapers

Company News

Recent posts

In October 2008, 851, the company also developed new products to improve the immunity and obtained the approval certificate

2021-02-24

Advising consumers

2021-02-24

Yang Zhenhua 851 Get 1000 Shanghai Cancer Rehabilitation Club free trial of patients signing ceremony in Yung

2021-02-24

Copyright © Fujian Yang Zhenhua 851 Bio-Science Co., Ltd  Powered by www.300.cn

Business Licence   SEO